#Ultrasound Program Canada

[cnih]

Are you in search of an Ultrasound Program in Ontario? We are just a phone call away from you. We provide an inspiring and empowering environment for students to cultivate their knowledge and skills under the top faculties of education in the country. At CNIH, we pride ourselves on the functionality, practicality and appearance of our facilities. For more information, you can call us at 613.726.CNIH (2644) or 1.866.726.CNIH (2644).

[pharmamedicalca]

Get Enroll in Canada's Best Sonography Course

Pharma-Medical Science College of Canada offers one of the best sonography courses that empower students to develop both theoretical and clinical expertise in different domains, including Abdomen and Small Parts, Gynecology, Obstetrics, Abdominal Vascular, minor Musculoskeletal, and Pediatric Sonography.

For more details, visit: https://pharmamedical.ca/programs/medical-health/diagnostic-medical-sonography-probationary/

[fearfulfertility]

CONFIDENTIAL REPORT

DRC, Intelligence Division, Rapid Response Command

To: Director [REDACTED]

From: Chief Operating Officer [REDACTED]

Date: [REDACTED]

Subject: Large-Scale Canadian Surrogate Conscription

EXECUTIVE SUMMARY

Following Operation Maple Harvest, the nation of Canada was successfully annexed into the greater continental American territory, and the Department of Reproductive Compliance (DRC) has significantly expanded its operational reach.

With the integration of former Canadian territories into our oversight, the agency has successfully implemented surrogate capture and processing programs at an unprecedented scale. Reports indicate that over [REDACTED] viable surrogates have been conscripted in the first [REDACTED] months of post-annexation governance, with projections suggesting an exponential increase in the coming year before stabilizing the following year.

This report provides an overview of tactical enforcement strategies, territorial control measures, and logistical efficiencies that have enabled mass conscription efforts in the former Canadian provinces.

I. STRATEGIC TERRITORIAL CONTROL

With the dissolution of the Canadian federal government, all former provinces and territories have been absorbed into the newly established FEMA Zone 13 (Western Canada), FEMA Zone 14 (Central Canada), and FEMA Zone 15 (Atlantic Canada).

Immediate DRC oversight has focused on establishing the following:

Cross-Border Tracking Systems: Utilizing existing intelligence networks to identify high-value surrogate candidates from former Canadian census records and healthcare databases. Special emphasis should be placed on former military personnel, athletes, [REDACTED], and blue-collar workers as the most fertile and rebellious groups.

Paternity Compound Development: The rapid repurposing of former military bases, university dormitories, and correctional facilities to house surrogates en masse, as they already have established barracks facilities.

Conscription Quotas & Enforcement: Coordinate with regional compliance officers to ensure capture rates meet federal reproductive mandates while assimilating the Canadian workforce into the DRC and normalizing surrogacy conscription. 

II. MASS SURROGATE CONSCRIPTION OPERATIONS

The newly annexed Canadian territories have provided an unparalleled expansion of surrogate stock, primarily due to the favorable demographic conditions of the population. Initial surveys indicate that:

[REDACTED]% of identified surrogates are of prime fertility age (18-25).

[REDACTED]% of captured surrogates display favorable genetic markers, exceeding standard thresholds.

KEY CONSCRIPTION STRATEGIES

University Raids: Focused efforts on collegiate sports teams have yielded a [REDACTED]% success rate in acquiring prime surrogates while reducing the number of educated dissenters.

Nighttime Extraction Teams: The deployment of low-profile, plain-clothes retrieval units has resulted in the seamless collection of over [REDACTED] surrogates per week without significant public resistance.

Border Detainment Facilities: The closure of major highways and railway hubs has effectively trapped fleeing candidates, ensuring no viable surrogates escape the zone.

Employment-Based Luring Programs: Former Canadian job assistance programs have been repurposed as recruitment traps, attracting young men under the guise of “Federal Relocation Initiatives.”

III. KEY INCIDENT REPORTS

Case Study #1: Mass Athletic Securing Operation

At 02:15, a DRC enforcement unit conducted a conscription raid at the University of [REDACTED]'s athletic dormitories. Surveillance data confirmed that [REDACTED] athletes met the biological and age criteria for surrogate eligibility.

Outcome:

All surrogates were secured and inseminated on-site, with only minor resistance and injury.

Post-capture ultrasounds confirmed exceptionally high fetal loads, with three surrogates being flagged to be carrying octodecuplets (18).

Notably, members of the track and field teams averaged higher fetal loads (15-18 babies) than their peers on football, hockey, and basketball teams (12-16 babies).

"I thought being an athlete was supposed to make things easier… but it just made me a better surrogacy candidate. I'm so huge with these babies I can't even stand up, let alone run. My belly’s enormous, and it's like I'm being stretched tighter every hour. It's humiliating. I'm completely immobilized, pinned down by my own pregnancy, helpless, and at their mercy. No one warned me it would feel this intense." - Surrogate SC003-182-O

Case Study #2: Highway Roundup Operation

In coordination with the new administration for FEMA Zone 14, roadblocks were established on Trans-Canada and Perimeter Highways. Over [REDACTED] young men attempting to flee westward were intercepted.

Outcome:

[REDACTED] individuals identified as prime surrogate candidates were detained, dosed with high-potency aphrodisacs, inseminated, and transferred to the newly opened Paternity Compound C-005, formerly the Canadian Museum for [REDACTED].

Non-fertile individuals who aided or participated in the attempted escape were transferred to local law enforcement for detainment. As the Canadian legal system is suspended until a new regional administration is appointed, individuals are redirected to work programs supporting the expansion of Paternity Compound C-005.

Detainment and insemination on the highway allowed for new surrogates to be rapidly transported to nearby facilities. 

"We thought we could make it out, but they had every route blocked—now I'm stuck here, pregnant with so many babies I lost count. I’m so enormous I haven't moved from this bed in days; just breathing makes me dizzy, and every kick sends shivers through me. The officers who caught us said we'd serve as 'examples,' and now I get why—my body's not even mine anymore, swelling bigger by the hour." - Surrogate SC002-105-M

Case Study #3: "Warehouse Party" Capture Operation

At 19:42, local security forces uncovered a "warehouse party" inside a former natatorium complex (i.e. community swimming pool) in downtown Montreal. Surveillance drones detected over [REDACTED] conscription-eligible men in attendance.

Outcome:

Under Emergency Security Powers [REDACTED], the crowd was detained without apparent escapes.

Emptied swimming pools were convenient hold areas while local law enforcement screened candidates for fertility or detainment.

[REDACTED] surrogates secured and inseminated within 30 minutes. The highest single mass insemination in the last [REDACTED], second only to the New Philadelphia incident where [REDACTED] candidates were inseminated.

Post-capture ultrasounds confirmed exceptionally high fetal loads. One surrogate, SC004-118-V, was flagged to be carrying duovigintuplets (22).

"We were just having a good time, you know? Then suddenly, we're herded into an empty pool like cattle, tested, and next thing I know, I'm more pregnant than I ever thought possible… I never knew anyone could grow this fast! My belly's so enormous I'm stuck here, and every time the babies kick...I can't stop thinking about how much bigger I'm still gonna get." - Surrogate SC005-111-N

Case Study #4: Public Birth Demonstration

On [REDACTED], intelligence units intercepted communications indicating that former municipal leader Mr. [REDACTED], residing within FEMA Zone 14 (Central Canada), attempted to incite rebellion against newly established governance. 

Outcome:

Immediate apprehension of Mr. [REDACTED] and the conscription of [REDACTED], his 19-year-old son, Surrogate ID: SC06-202-Q.

SC06-202-Q was inseminated and confirmed to be pregnant with septendecuplets (17), an exceptionally high fetal load, resulting in rapid physical changes and eventual immobilization.

The surrogate reached a final pregnancy weight of 527 lbs (239 kg), rendering him completely immobile and dependent on medical staff for all movement and care.

Public Demonstration:

Scheduled the surrogate’s delivery as a mandatory public event in a local open-air square, attended by the local population, and broadcast on all local channels. Mr. [REDACTED] was restrained in a front-row seat with an unobscured view of the event.

The surrogate publicly induced and entered active labor at precisely 14:00, with all 17 fetuses delivered successfully over 4 hours.

Crowd reactions ranged from shock and discomfort to subdued apathy, effectively curtailing further open resistance in the region.

"They forced us all out there to watch—it was… I can’t describe what it was. The surrogate was massive, all you could see were his splayed legs and gigantic womb. I've never seen anything like it… he was groaning and shaking the whole time, his belly so big I swore it was gonna burst. Every time another baby came out, he let out these noises—it was like he couldn't even tell where he was anymore. Honestly, I couldn't look away, as shocking as it was." — [REDACTED], Local Resident

IV. FUTURE EXPANSION & PROJECTED OUTCOMES

The annexation of Canada has significantly exceeded expectations, proving to be one of the most fertile territories available for surrogate conscription. Future efforts will focus on the following:

Paternity Compound Expansion: Construction of five new high-capacity compounds in [REDACTED], Ottawa, and [REDACTED] City.

Mobile Paternity Units: Deployment of MPUs to secure and inseminate hard-to-reach rural populations.

Mass Public Compliance Initiatives: Implement “Surrogacy Service Announcements” and “Volunteer Reproductive Compliance” programs to normalize forced conscription within newly annexed regions.

Cross-Border Transfer Policies: [REDACTED]% Canadian surrogates to be transferred across the border to ensure their security as local seditious groups are eliminated.

CONCLUSION

The annexation of Canada represents a historic victory for the Department of Reproductive Compliance, ensuring a massive influx of high-value surrogates into North American breeding programs. While some initial resistance has been recorded, ongoing security operations confirm that disruptions to insemination activities are minimal, and the number of pregnant Canadian men continues to increase dramatically.

Prepared by:

Chief Operating Officer [REDACTED]

DRC, Intelligence Division, Rapid Response Command

----------------

Click Here to return to DRC Report Archives

[orcinus-veterinarius]

The Orchive

Get it? Orchive? Orca?

Below is a master list of (mostly) my original posts that address frequently asked questions! This is a living document and may not be comprehensive. I also utilize an extensive tagging system!

Some of these answers are older. Feel free to ask a question again, and I’ll let you know if my thoughts have grown at all.

Please note that some topics contain multiple links, so look carefully!

Zoos & Aquariums (General)

How do I know if a zoo is ethical?

Stereotypical behaviors

Unethical animal sanctuaries

Are there "good" sanctuaries?

Why are so many zoos "for-profit"?

Elephants in zoos

Zoos & Aquariums (Specific)

The Beluga Whale Sanctuary

Clearwater Marine Aquarium

The National Aquarium

Disney's Animal Kingdom

Greensboro Science Center

SEA LIFE aquariums

Gulfarium Marine Adventure Park

Brookfield Zoo

Dolphin Quest (and Dolphin Connection)

SOS Dolfijn

Killer Whales & SeaWorld

Why I'm "pro captivity"

Is SeaWorld AZA accredited?

What about Blackfish?

How SeaWorld helps animals

SeaWorld's marine rescue program

Why is public sentiment against SeaWorld?

Why do orcas' dorsal fins collapse in human care?

Should whales and dolphins have larger tanks?

SeaWorld's killer whale breeding program

Life expectancy of SeaWorld's killer whales

Should SeaWorld have ended their breeding program?

Why did SeaWorld use artificial insemination?

Are killer whales "too smart" to be in captivity?

Why does SeaWorld teach their orcas to do "circus tricks"?

Keiko (Free Willy)

Tilikum

Tokitae

Morgan

Dawn Brancheau

Toa & Ingrid Visser

Kiska & Marineland Canada

Killer Whale Ecotypes

Should Tokitae move to SeaWorld?

Why are those orcas attacking boats?

How do whales sleep?

Other Cetaceans

What's it really like for a whale or dolphin in an aquarium?

Aren't scientists against cetacean captivity?

What are some sources supporting cetaceans in human care?

What do we learn from having cetaceans in aquariums?

Do dolphins do well in captivity?

Don't wild dolphins swim hundreds of miles a day?

How long do dolphins live in captivity?

Swim-with-dolphins Programs

Dolphin shows

Wild dolphin tours

Do dolphins enjoy being touched?

US Navy Marine Mammal Program

Hvladimir the "Russian Spy Whale"

Indoor vs Outdoor marine mammal habitats

Why reproduction is important to cetacean welfare

Opposing the SWIMS Act

Cetacean ultrasounds

Why sea pens aren't the perfect solution

How come we can't just free the dolphins?

Are dolphins still captured from the wild?

Pets

Adopt don't shop?

Vet Medicine & Vet School

Zoo opportunities for vet techs

Client abuse

Animal Rights vs Animal Welfare

Veal crates

Dairy hutches

Dissections

Animal rights groups spread misinformation

Why don't you support the Humane Society of the United States?

Do you support the ASPCA?

Trophy hunting

Other

Commercial fisheries

Shark finning

Red wolves

Fun facts about eels

[thoratketan]

Global Mammography Workstations Market: Analysis Of Market Segmentation And Trends

The global Mammography Workstations Market was valued at USD 152.75 million in 2023 and is projected to reach USD 264.42 million by 2031, growing at a compound annual growth rate (CAGR) of 7.1% over the forecast period from 2024 to 2031. The rising incidence of breast cancer, increased awareness around early detection, and advancements in diagnostic imaging technologies are major contributors to the growing demand for mammography workstations worldwide.

Get Free Sample Report on Mammography Workstations Market

Mammography workstations are specialized systems used by radiologists and clinicians to view, interpret, and analyze breast images acquired through mammographic imaging systems. With the global healthcare community placing greater emphasis on early cancer detection, these workstations have become indispensable tools in modern diagnostic imaging workflows.

Market Overview

Mammography workstations serve as an interface between imaging systems and diagnostic decisions. These platforms provide high-resolution displays, integrated tools for image enhancement, comparison features, and compatibility with other imaging modalities such as ultrasound, MRI, and tomosynthesis. As breast cancer screening programs expand globally, and digital mammography becomes more prevalent, the need for efficient, scalable, and intelligent workstations continues to rise.

The market's growth is further accelerated by the shift from traditional film-based imaging to fully digital workflows, which allow for improved image quality, faster results, remote consultation, and reduced storage and processing costs.

Key Growth Drivers

Rising Prevalence of Breast Cancer Breast cancer is one of the most common cancers affecting women worldwide. According to the World Health Organization (WHO), early detection is key to improving survival rates. Mammography remains the gold standard in breast cancer screening, and high-performance workstations are critical in enabling accurate diagnosis and timely intervention.

Technological Advancements in Mammography Imaging Innovations in digital mammography, such as 3D tomosynthesis, contrast-enhanced mammography, and AI-powered image analysis, are enhancing diagnostic accuracy and expanding the functionality of workstations. Modern mammography workstations now feature advanced algorithms that aid in detecting lesions, analyzing dense breast tissue, and minimizing false positives or negatives.

Growing Adoption of Digital Healthcare Infrastructure The global push toward digitalization in healthcare has accelerated the adoption of PACS (Picture Archiving and Communication Systems), RIS (Radiology Information Systems), and integrated imaging platforms. Mammography workstations are now required to offer interoperability, remote access, and seamless integration with hospital IT systems for efficient reporting and data sharing.

Government Screening Initiatives and Awareness Campaigns Public health programs promoting routine breast cancer screening are creating a surge in mammogram volumes, particularly in developed markets like the U.S., Canada, the U.K., and Australia. Emerging economies are also scaling up national screening programs, contributing to increased demand for diagnostic imaging infrastructure, including dedicated workstations.

Radiologist Workflow Optimization With a growing number of medical images generated daily, healthcare providers are under pressure to improve efficiency without compromising diagnostic accuracy. Mammography workstations streamline the radiologist’s workflow, offering tools for image comparison, automated measurements, and AI-assisted interpretation, enabling faster and more confident diagnoses.

KEY MARKET SEGMENTS:

By Modality type

Multimodal

Standalone

By Application

Diagnostic screening

Advance imaging

Clinical review

By End-use

Hospitals

Breast care centers

Academia

Competitive Landscape

The mammography workstation market is moderately competitive, with key players focusing on technological upgrades, artificial intelligence integration, and expansion into untapped markets.

Leading companies in the market include:

Hologic, Inc.

Siemens Healthineers

GE HealthCare

FUJIFILM Holdings Corporation

Agfa-Gevaert Group

Konica Minolta, Inc.

Sectra AB

Barco NV

Carestream Health

Planmed Oy

These companies are investing in R&D and AI-based diagnostic tools that enhance workflow automation, clinical decision support, and interoperability with other imaging systems.

Make Enquiry about Mammography Workstations Market

Future Outlook

The future of the mammography workstations market lies in smart imaging, cloud-based diagnostics, and AI-driven decision support. As personalized medicine and early detection gain momentum, workstations capable of synthesizing multimodal data and assisting radiologists in real-time will become central to breast cancer care.

Furthermore, increasing investments in telemammography and mobile screening units in rural and underserved regions are expected to further boost demand. Vendors that offer cost-effective, scalable, and interoperable workstation solutions will be well-positioned to capitalize on the expanding global market.

 About US

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

 Contact Us:

Jagney Dave - Vice President Of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

[medfertility]

Surrogacy Cost in Kazakhstan – A Complete Guide for Intended Parents

Surrogacy has emerged as a ray of hope for couples and individuals who are unable to conceive naturally. Among the growing list of international surrogacy destinations, Kazakhstan is gaining popularity for its progressive laws, modern fertility clinics, and comparatively affordable pricing. If you’re exploring options for family building, understanding the Surrogacy Cost in Kazakhstan is essential before starting your journey.

Kazakhstan offers a favorable legal and medical environment for both local and international intended parents. It is one of the few countries in Central Asia where surrogacy is legally regulated and supported by an established medical infrastructure. Moreover, the cost of surrogacy in Kazakhstan is significantly lower than in countries like the United States, Canada, or the UK — without compromising the quality of medical care.

Understanding Surrogacy in Kazakhstan

Surrogacy in Kazakhstan is legally permitted and regulated under civil and family law. Only gestational surrogacy is allowed, meaning the surrogate mother has no genetic connection to the baby. The intended mother’s or donor’s egg and the intended father’s or donor’s sperm are used to create the embryo.

This ensures legal clarity, as the surrogate does not hold parental rights over the child. Married heterosexual couples and single women with medical reasons preventing pregnancy are allowed to pursue surrogacy in Kazakhstan.

Surrogacy Cost in Kazakhstan — What to Expect?

The Surrogacy Cost in Kazakhstan ranges from $35,000 to $50,000, depending on the clinic, legal services, surrogate compensation, and medical procedures involved. This cost typically includes:

1. Initial Medical Screenings and Consultations

Fertility assessments for intended parents

Blood tests, ultrasounds, and hormonal evaluations

Surrogate screening (medical and psychological)

Estimated cost: $2,000 — $3,000

2. IVF Procedure and Embryo Transfer

Ovarian stimulation and egg retrieval

Sperm processing and fertilization

Embryo culture and transfer into the surrogate

Estimated cost: $5,000 — $8,000

3. Surrogate Compensation

This is one of the major components of the overall cost. The surrogate is compensated for her time, effort, and the physical and emotional demands of pregnancy.

Estimated cost: $10,000 — $18,000 (varies by case and agreement)

4. Legal and Documentation Fees

Drafting and signing the surrogacy contract

Legal representation for both parties

Birth certificate issuance and parental rights registration

Estimated cost: $3,000 — $5,000

5. Prenatal Care and Delivery

Regular check-ups and scans during pregnancy

Maternity hospital charges and delivery fees

Emergency care if needed

Estimated cost: $8,000 — $12,000

6. Agency or Coordination Fees

Agencies or coordinators assist with the entire process, from matching with a surrogate to coordinating appointments and legal steps.

Estimated cost: $5,000 — $8,000

For expert assistance and a comprehensive surrogacy program, many intended parents turn to trusted facilitators like Med Fertility. Known for ethical practices and transparent pricing, Med Fertility supports intended parents through every stage of the surrogacy process — from initial consultation to bringing the baby home.

📞 Contact Us: +91–701669315 📩 Email Us: info@medfertility.com

Why Choose Kazakhstan for Surrogacy?

Kazakhstan offers several advantages that make it a desirable destination for surrogacy:

✅ Legal Clarity — Surrogacy is clearly defined and protected under the law, offering peace of mind to intended parents. ✅ Affordable Pricing — Compared to Western countries, the Surrogacy Cost in Kazakhstan is significantly lower. ✅ High-Quality Medical Facilities — Fertility clinics in Kazakhstan are equipped with advanced reproductive technologies and trained professionals. ✅ Availability of Surrogates — The surrogate matching process is relatively quicker, helping to reduce waiting times. ✅ Multilingual Services — English-speaking coordinators and legal professionals ensure seamless communication throughout the process.

Tips to Manage Surrogacy Expenses Wisely

💡 Choose a Reliable Agency — A trusted coordinator or agency helps manage finances efficiently and avoid hidden costs. 💡 Understand the Legalities — Ensure that all contracts are clear and protect your parental rights. 💡 Ask About Inclusions and Exclusions — Make sure your package includes medical care, legal services, and surrogate compensation. 💡 Plan for Travel and Accommodation — Budget for travel costs to Kazakhstan during key process stages.

Who Should Consider Surrogacy in Kazakhstan?

Surrogacy is a valuable solution for:

Women with medical conditions making pregnancy risky or impossible

Couples who’ve experienced multiple IVF failures or miscarriages

Individuals with uterine abnormalities

Single women (as per Kazakhstan’s legal eligibility)

Kazakhstan’s supportive environment and structured legal system make it a reliable and cost-effective option for growing families.

Take the First Step Toward Parenthood

Choosing the right surrogacy destination is a deeply personal and life-changing decision. With its balanced affordability, legal support, and medical excellence, Kazakhstan stands out as an ideal choice.

If you’re considering surrogacy, let Med Fertility guide you through every step of the process — from matching with a surrogate to welcoming your baby home with confidence and care.

📞 Contact Us: +91–701669315 📩 Email Us: info@medfertility.com

[credenceresearchdotblog]

The Cardiac Ultrasound Systems Market is projected to grow from USD 1,444.5 million in 2024 to USD 2,794.83 million by 2032, registering a compound annual growth rate (CAGR) of 8.6% during the forecast period. The global cardiac ultrasound systems market is experiencing significant growth, driven by the increasing prevalence of cardiovascular diseases (CVDs), technological advancements, and a growing emphasis on early diagnosis and preventive healthcare. As of 2025, the market is valued at approximately USD 2.6 billion and is projected to reach USD 3.45 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3% during the forecast period.

Browse the full report at https://www.credenceresearch.com/report/cardiac-ultrasound-systems-market

Market Drivers

Rising Incidence of Cardiovascular Diseases: CVDs remain the leading cause of mortality worldwide, accounting for a significant number of deaths annually. The World Health Organization reports that about three-quarters of these deaths occur in low- and middle-income countries. This alarming trend underscores the need for effective diagnostic tools, such as cardiac ultrasound systems, to facilitate early detection and management of heart conditions.

Technological Advancements: The field of cardiac ultrasound has witnessed remarkable technological progress, including the development of 3D and 4D imaging, Doppler ultrasound, and portable handheld devices. These innovations have enhanced image quality, diagnostic accuracy, and accessibility, enabling healthcare providers to offer point-of-care services even in remote locations.

Emphasis on Preventive Healthcare: There is a growing global awareness of the importance of early diagnosis and preventive measures in healthcare. Cardiac ultrasound systems play a pivotal role in non-invasive cardiac assessments, allowing for timely intervention and improved patient outcomes.

Challenges and Opportunities

While the market is poised for growth, it faces challenges such as the high cost of advanced ultrasound systems and a shortage of skilled professionals to operate these devices. However, these challenges present opportunities for market players to invest in training programs and develop cost-effective solutions tailored to emerging economies.

Future Outlook

The cardiac ultrasound systems market is on a robust growth trajectory, propelled by technological innovations, increasing healthcare awareness, and the pressing need to address the global burden of cardiovascular diseases. As healthcare systems worldwide continue to prioritize early diagnosis and preventive care, the demand for efficient and advanced cardiac ultrasound systems is expected to rise, offering lucrative opportunities for existing and new market entrants.

Key Player Analysis

Siemens Healthineers AG

Canon Medical Systems Corporation

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)

Koninklijke Philips

Esaote SpA

Samsung Medison Co. Ltd.

Hitachi Medical Corp.

Fujifilm Sonosite, Inc.

Health Catalyst (KPI Healthcare Inc.)

GE Healthcare

Segments:

Based on Type

Transthoracic echocardiography

Transesophageal echocardiography

Stress echocardiogram

Others

Based on Technology

2D

3D/4D

Doppler

Based on Display

Colour display

Black & white (B/W) display

Based on End-use

Hospital

Diagnostic centers

Ambulatory care centers

Others

Based on the Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/cardiac-ultrasound-systems-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

[industrynewsupdates]

Breast Imaging Market: Key Trends and Growth Opportunities

The global breast imaging market size is anticipated to reach USD 9.0 billion by 2030, registering a CAGR of 8.6% according to a new report by Grand View Research, Inc. The market growth mainly owes to the increase in the number of women suffering from breast cancer. For instance, according to Robert Koch Institute, the annual incidence of breast cancer in Germany was estimated to be approximately 72,000, with breast cancer being the most prevalent cancer in women. Moreover, as per a similar source, based on the incidence rate, one in eight women is expected to suffer from breast cancer once in a lifetime. Thus, impelling the market over the forecast period.

Furthermore, the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of breast cancer are anticipated to increase the demand for breast imaging. For instance, Pink Initiative, form Breast Cancer India is an online initiative program in which the program covers important topics such as early detection of breast cancer, and familial breast cancer, through their YouTube channel. Similarly, a joint initiative between Australian & state territory governments, ‘BreastScreen Australia’ is aimed at reducing deaths & illness from breast cancer by early detecting cancer. In this program, women aged 40 and above can have a free mammogram every 2 years. This is expected to increase awareness, and increase the demand for breast imaging, thereby, propelling the market growth.

Major manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, The MAMMOMAT Revelation platform, from Siemens Healthineers, for enhanced mammography has been approved by the U.S. FDA. To target afflicted areas with only one click, this platform combines a new InSpect specimen imaging tool and new HD Breast Biopsy technology. In addition, the use of artificial intelligence (AI) in breast imaging has reduced the time required while maintaining image quality. Such product developments are expected to propel market growth.

Gather more insights about the market drivers, restrains and growth of the Breast Imaging Market

Breast Imaging Market Report Highlights

• The ionizing segment dominated the technology segment in 2022 owing to the introduction of new ionizing technology-based breast imaging technologies.

• Hospitals dominated the end-use segment in 2022 due to the presence of advanced and well-equipped breast imaging facilities.

• In 2022, North America dominated the breast imaging market with a market share of 37.87% 2022. This can be accredited to the rising number of breast cancer cases in this region.

• Asia Pacific is projected to impel at the fastest growth rate of CAGR 9.5% during the forecast duration. Increased prevalence of breast cancer, high R&D investments in breast cancer therapies, and developments in breast imaging modalities are the primary drivers driving the growth of the market.

Breast Imaging Market Segmentation

Grand View Research has segmented the global breast imaging market based on technology, end-use, and region:

Breast Imaging Technology Outlook (Revenue, USD Million; 2018 - 2030)

• Ionizing

o Full-field Digital Mammography

o Analog Mammography

o Positron Emission Mammography

o Electric Impedance Tomography

o Cone-Beam Computed Tomography

o Positron Emission Tomography & Computed Tomography

o 3D Breast Tomosynthesis

o MBI/BSGI

• Non-ionizing

o MRI

o Thermography

o Ultrasound

o Optical Imaging

o Automated Whole-breast Ultrasound

Breast Imaging End-use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals

• Breast Care Centers

• Diagnostic Imaging Centers

Breast Imaging Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o India

o China

o Australia

o Thailand

o South Korea

• Latin America

o Mexico

o Brazil

o Argentina

• MEA

o South Africa

o Saudi Arabia

o Kuwait

o UAE

Order a free sample PDF of the Breast Imaging Market Intelligence Study, published by Grand View Research.

[phawareglobal]

Lisa Mielniczuk, MD - phaware® interview 501

Dr. Lisa Mielniczuk, a cardiologist at the Mayo Clinic in Rochester, shares her personal journey of becoming interested in pulmonary hypertension and the challenges faced by patients in accessing care. Dr. Mielniczuk emphasizes the importance of building connections with patients and involving them in decision-making. She discusses the CRAVE study, which aims to test novel and repurposed therapies for right heart failure using a platform trial design. She highlights the importance of patient involvement in the trial design and its upcoming feasibility study.

My name is Lisa Mielniczuk. I am a cardiologist and Sr. Associate Consultant at the Mayo Clinic in Rochester, formerly from the University of Ottawa Heart Institute in Ottawa, Canada for many years. I am a specialist in what's called advanced heart disease. So, my area of interest and specialty is looking after patients with very serious and complex heart disease. That includes things like heart failure. I look after patients who have or have had or need a heart transplant, as well as patients who require mechanical circulatory support or heart pumps to help to keep them well. I would say quite honestly that one of my biggest interests and passions in my career thus far has been being involved in the pulmonary hypertension community and looking after patients with pulmonary hypertension.

I'm really excited to talk to you a little bit more about some of the research that is launching here in Canada to help to improve the outcomes of our patients with pulmonary hypertension and right heart failure. 

Before I do that, though, maybe I'll tell you a little bit about myself in terms of why I got interested in the field of pulmonary hypertension. That was many, many years ago when I first started my clinical practice, I was on staff probably about a year or less, and I was working in the intensive care unit. We had admitted a patient with heart failure and she was a very young girl. She was only 19 years old, very nervous, appropriately so.  It was quite obvious to all of us that she was very sick.

Now, initial echocardiogram or ultrasound of her heart showed that she had significant right heart failure and she had severe pulmonary hypertension. She was very unwell and a very high-risk patient. Immediately, all of us as a team rallied and wanted to do everything we could to help her in this journey of diagnosis and management. In fact, actually very quickly, it became apparent that this wasn't the first step in her diagnosis. In fact, she had had symptoms for many, many months before she came into the intensive care unit. Like many patients with pulmonary hypertension, her symptoms were attributed to other things, other things that might be more common in a woman with shortness of breath. That, like for many of our patients, led to a delay in her diagnosis. So, by the time she had her diagnosis, unfortunately, she was very ill. That was an important realization for us that we needed to do better.

Then, there was a second realization that happened in the care of this patient. That was that, at that time, many years ago, in the infrastructure in Ottawa, we did not have a Pulmonary Hypertension Clinic. In fact, we didn't have a PH program at all. So, all of our patients that were diagnosed or needed treatment for pulmonary hypertension had to either go to Montreal, which is about two hours away, or to Toronto, which is about four and a half hours away. We ended up transferring the patient to the excellent care of the Toronto program, and she did very well. But can you imagine being told that you have a very serious disease and then being told that you now have to be transferred away from your family, away from your home, to an external institution to receive care and treatment? It was right then that I knew that, in Ottawa we needed to do better. We needed to do better for our patients and our community. 

So, along with some incredible collaboration with a colleague of mine from the pulmonology side and some excellent collaboration with nursing support from the Heart Institute and even support from industry partners, within a year, we were able to start a PH Clinic here in Ottawa. Our little program grew. I'm really happy to say that now we are certainly one of the larger programs in the country and really actively involved in research, support, and education. We've really been fortunate to make a huge difference to the care and the quality of our patients with pulmonary hypertension. That's a little aside, but it tells you a little bit about our story, and why I'm here, and why I think being here is so important. 

One of the things that I think is just as important as the medical therapy of pulmonary hypertension is the connection that we build with our patients. Myself and my colleagues have been really lucky to work very closely with incredible patient partners and organizations to unite our community. I've been working with Pulmonary Hypertension Association of Canada for many years now, previously as vice chair. I can tell you quite honestly that it is probably the most fun part of my work. In everything we do, we realize how important it is that we have our patients and our caregivers first and foremost with all the decisions we make. 

With that as kind of an introduction, I'd like to tell you a little bit about some of the research that we do. Now, my area of research interest for many years now has been in the field of right heart failure. Now, if you haven't heard of that before, and I tell my patients all the time, "Heart failure sounds like a terrible thing, right. My heart is failing," and we need to come up with a better term for that. But essentially, what that means is almost you can think of it as a supply-demand mismatch between what your heart is able to give in terms of cardiac output and blood flow through your body and what your body needs to feel well to do the things that we love to do, whether it's exercise or even walking, talking sometimes just eating and feeling comfortable at rest. Whenever there's an imbalance there where the heart is unable to provide the needs of our body with what we need to feel well, we develop the symptoms of heart failure. Those symptoms can include things like shortness of breath, fatigue, chest discomfort, fluid retention, exercise intolerance. Unfortunately, many of our patients that live with pulmonary hypertension are at risk of developing right heart failure.

Now, why is right heart failure so important? It's very important for a number of reasons, but I'm going to share with you probably two that have really inspired me to do the research that I'm doing. The first is that right heart failure is one of the most important predictors of what we call prognosis. How we determine how we need to worry about a patient in the short or long term? We know that if patients develop symptoms of right heart failure, that they're going to struggle a lot more. So, it's a very, very important thing to identify. 

The other thing that's known about right heart failure is it's not so much the severity of the pulmonary hypertension or how high the blood pressure is in your lungs that determines whether or not you get right heart failure. It's a much more complicated algorithm. In fact, we don't even know all the pieces of what makes somebody predisposed to right heart failure and what makes somebody relatively spared from right heart failure. But those are some of the things that in my research I've been trying to answer over the last few years. 

The second thing that I want to share about right heart failure is that unlike left heart failure, which is a very common type of heart failure that I also look after in other clinics, in other areas of my job, the treatments for right heart failure are very, very limited. In fact, we have great medications that work really, really well on failure of the left heart to improve quality of life, improve survival, and actually sometimes even improve pumping function of the heart. Yet, those same medications, when applied to the right side of the heart, are either shown to be not effective or, in some cases, dangerous. So, there's a lot of uncertainty about how we identify right heart failure, how we predict right heart failure, and importantly, how we treat right heart failure.

This is where we are focusing on our energy. My colleague, Dr. Jason Weatherald, and I have been talking about this for quite a few years now, because we want to develop a research line of focus that can help us to move forward faster and more efficiently, potential treatments for right heart failure. One of the things that we think is very, very important when we're talking about clinical research is when we used to do clinical research many, many years ago, it was really thought about from the level of the healthcare professional. The study was designed by the healthcare professional. We enrolled patients who participated in the clinical study, and then we analyzed the results and came up with conclusions. We hoped that the patients would agree with our conclusions, but they historically weren't given a lot of information or attention into how those results may impact them.

I can say very gladly that the landscape for this has changed quite dramatically. We now understand that for medication to be successful, for patients to take medications and feel good about medications and be engaged in the whole interaction of their clinic encounter with their healthcare team, they have to be at the table. Not only do they have to be at the table, but they are the most important part of the conversation. So, one of the things that we're trying to do with our CRAVE study is engage our community partners, our patient partners, our people with lived experience, and their caregivers at every step of a clinical trial design. What that means is we want to know what matters to our patients. What clinical endpoints in a clinical trial are relevant to them? What type of clinical study would they feel comfortable participating in? What type of clinical study would they feel very uncomfortable with? What sort of result would be meaningful to them, so meaningful that they might actually feel very good about taking a particular therapy, or what sort of result would be not consistent what they think is in their best interest? So, with CRAVE intertwined into the design of our project is going to be partnership, and we've been so grateful to have excellent partnership through PHA Canada to really engage our patients at every step of the trial design. 

The last thing I'd like to say is just to tell you a little bit about the trial design. As you might imagine, from everything I've been saying, CRAVE is designed to look at novel or potentially repurpose therapies for right heart failure. By repurposed, I mean treatments that have been shown to be effective in one clinical condition to see whether or not they're effective in patients with chronic right heart failure. One of the things that we've also struggled with in the land of pulmonary hypertension and right heart failure research is it's very hard to do large clinical trials, because we know that there are not hundreds and hundreds and hundreds of thousands of patients with pulmonary arterial hypertension. 

Oftentimes, clinical trials are smaller as a result, and their endpoints or their results may be limited because you may not have enough power in the study to find a meaningful result. One way around that is a novel statistical design called a Platform Trial. That's what we are trying to build with CRAVE, whereby not only are we testing one treatment at a time, but we may, in fact, be testing multiple treatments at a time in different scenarios and over different arms. By following things very closely, we might be able to identify, early on, a clear winner of these early studies, a drug that shows a lot of promise, and we can shift the design and the nature of the study to preferentially enroll patients in a treatment that might be showing good promise.

Alternatively, in a treatment that may not be showing very good promise, we can stop studying that treatment earlier on and shift our focus without having to end a study and start over again and, therefore, lose time. We had meetings in Edmonton, Alberta, recently of a number of engaged stakeholders and community partners to sit down for a day and a half and really just talk about what would this CRAVE trial look like. What sorts of things are important to us, what therapies might be good candidates to trial, and how might we launch this as we go forward? I'm really excited about the next steps. We are in the process of launching what we call a Feasibility Study, which is sort of a mini-scale version of what we anticipate the larger trial may be, and we're very, very excited about launching this in Canada in 2024.

But we're also really hopeful that we'll be able to partner with some excellent colleagues and friends in the United States and potentially consider this a North American initiative, because we do feel that it is so important. We are really excited about this new day of clinical trial research, where research is not just on the patients, but the patients and the caregivers, and everyone are working collaboratively together, all at the same table all at the same time. 

My name is Lisa Mielniczuk, and I am aware that my patients are rare.

Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Follow us on social @phaware Engage for a cure: www.phaware.global/donate #phaware Share your story: info@phaware.com @phacanada  #phawareMD #HeartWorksApp

Listen and View more on the official phaware™ podcast site

[hema60028]

Clinic physiotherapy in edmonton

physiotherapy is one of the Regulated Health Care professions in Canada and it plays a vital role for patients with acute or chronic painful conditions, headaches, mobility problems, postural abnormalities, weakness, balance impairments, instability, incontinence, concussion and vertigo. Physiotherapy utilizes Science based physical approaches such as Manual Therapy, Exercise Therapy and Pain-relieving modalities to improve, maintain and restore physical, psychological and social well-being and Physiotherapy has no adverse effects.

Our Physiotherapists (PT) are Registered (Licensed) members with Physiotherapy Alberta College + Association and directly accessible in Alberta without a Doctor’s referral. Our PTs are Manual Physical Therapists who have completed several courses in Canada after graduated from Physiotherapy schools.

Our PTs are Manual Physical Therapists who have completed several courses in Canada after graduated from Physiotherapy schools. Our PTs are also excellent to assess and treat all kinds of patients including Workplace injuries (WCB), Motor Vehicle accident (MVA) Injuries and Pelvic Health concerns. When you visit our clinic, Our PTs will do a unique, complete, comprehensive assessment in a an effective, safely manner without aggravating your problems and will be quickly able to find out the issues you have. They will explain about your condition as well as treatment options available to you after the careful assessment. Our clinic is apatient centred clinic and You have rights to choose or deny any treatment options given to you. Our PTs closely work with other health care providers including Medical Doctor and you will be referred to respective health care provider if it is deemed necessary by both yourself and the PT. Our PTs may apply the following Evidence Based Techniques depending upon your condition.

Manual Therapy

ROM exercises

Stretching exercises

Strengthening and Endurance exercises

Nerve mobility exercises

Balancing exercises

Postural correction strategies

Proprioceptive neuromuscular facilitation techniques

Motor control strategies

Muscle Energy Techniques (MET)

Trigger Point Release

Transverse friction

Graston techniques (IASTM )

Strategies to treat Vertigo

Home Exercise program

Dry needling

Acupuncture

Ultrasound

Shock Wave Therapy (SWT)

Custom made Foot Orthotics

Custom made Don Joy knee brace

Pain relieving modalities such as Hot Packs, TENS, EMS

[cnih]

For the Ultrasound Sonographer program in Canada, get in touch with us. Upon graduation and successful completion of the Generalist credentialing examinations (Sonography Canada) and entrance into the College of Medical Radiation Technologists of Ontario, graduates can choose to find employment as a generalist sonographer or specialize in a particular field. For more information, you can call us at 613.726.CNIH (2644) or 1.866.726.CNIH (2644).

[thereseduane]

ACS - Advancing Surgical Excellence

The American College of Surgeons (ACS) advances surgical care quality and standards globally. Its governance structure comprises а board of regents which formulates policies and governs college affairs, and a board of governors, which acts as a liaison between the Regents and Fellows.

For over a century, the ACS has leveraged its extensive international network to deliver high-quality surgical care. Its membership exceeds 90,000 across 144 countries and continues to expand. Each year, the ACS trains thousands of healthcare professionals across various specialties. It offers diverse membership categories to accommodate different career stages and professional needs.

The fellowship category is for surgeons practicing in the US or Canada. Associate fellow membership is for early-career surgeons within their first six years of practice, while the international category targets surgeons in international chapters with at least three years of experience. Non-surgeon operating room professionals and researchers fit in the affiliate category. Students enrolled in the US, Canadian, and international select medical schools can join the medical student membership category. Resident membership is for post-medical school trainees seeking to leverage ACS’ resources.

To maintain surgical excellence, the ACS provides ongoing education tailored to various professional levels, including residents, educators, and practicing or senior surgeons. Its curriculum covers critical topics, including ultrasound techniques like Focused Assessment with Sonography in Trauma (FAST) and thyroid, parathyroid, and neck ultrasound. The organization’s courses are designed to impart basic and advanced surgical knowledge and skills. Complementing these educational offerings, the ACS publishes research in areas like oncology and other medical fields, providing surgeons with the latest findings to integrate into their clinical practice.

The organization enhances its educational outreach by collaborating with other organizations for joint Continuing Medical Education (CME) programs. These partnerships leverage the accredited status of larger institutions, ensuring a streamlined process for awarding CME credits. Joint efforts further ensure that educational programs for physicians adhere to strict standards. The MyCME platform, accessible to ACS members and non-members, allows users to manage their CME requirements, including tracking credits earned from ACS-accredited courses and activities.

Recognizing patient engagement as crucial to surgical outcomes, the ACS extends its educational efforts to patients. Through resources like procedure-specific brochures, home-skill training videos, and other educational materials, patients can better understand what to expect before, during, and after surgery. This patient-centric approach promotes informed consent, enhances self-care skills, and improves pain management, improving surgical outcomes.

Additionally, ACS equips its members with essential practice management tools to enhance their surgical careers. These include comprehensive coding resources, such as current procedural terminology (CPT) coding (a listing of descriptive terms surgeons and staff use to report medical services and procedures). Members also benefit from contract review assistance, financial planning services, and telehealth support to broaden patient reach. ACS’ payor resources offer insights into payment policies from insurers, including the Medicare Physician Fee Schedule.

The ACS Foundation, an entity associated with the College, supports its initiatives through funding. Through donations from fundraisers and philanthropists, the foundation supports surgical research, fellowship programs, and scholarships. For instance, the Greatest Needs Fund supports critical College programs and initiatives advancing surgical education, research, and quality improvement. The Stop the Bleed initiative trains the public in emergency bleeding control techniques, empowering them to save lives before professional medical help arrives, while international efforts such as Operation Giving Back expand access to surgical care in underserved regions.

The foundation welcomes various forms of support, from online and credit card donations to stock transfers. Beyond financial contributions, it encourages volunteering, allowing supporters to further the organization’s mission.

[repromedcanada]

Egg Donor Toronto: What You Should Know Before Donating Eggs

Becoming an egg donor is a generous and life-changing decision that can assist couples struggling with infertility. If you are considering becoming an egg donor Toronto, it is essential to be well-informed about the process, requirements, and potential implications. This guide will provide you with a comprehensive understanding of what you need to know before donating eggs.

Requirements for Egg Donors

To become an egg donor, you must meet several criteria. Typically, egg donors are women between the ages of 21 and 34, as this age range represents the peak of fertility and health. Potential donors must undergo a series of medical and psychological evaluations to ensure they are suitable candidates. These assessments include:

Medical History Review: Physicians will review your personal and family medical history to identify any genetic disorders or health issues that could be passed on to the child.

Physical Examination: A comprehensive physical examination is necessary to ensure you are in good health.

Psychological Evaluation: This assessment ensures that you understand the emotional and psychological implications of donating eggs.

Blood Tests and Ultrasounds: These tests help determine your ovarian reserve (the number of eggs available in your ovaries) and overall reproductive health.

The Egg Donation Process

The egg donation process involves several steps, each crucial for a successful donation. Here is an overview of what to expect:

Screening and Matching: Once you pass the initial evaluations, you will be matched with a recipient. This matching process considers various factors, including physical characteristics, medical history, and sometimes the personal preferences of the recipient.

Ovarian Stimulation: You will begin taking hormonal medications to stimulate your ovaries to produce multiple eggs. This phase requires frequent visits to the fertility clinic for monitoring through blood tests and ultrasounds.

Egg Retrieval: When your eggs are ready, a minor surgical procedure is performed to retrieve them. This procedure, known as follicular aspiration, involves using a thin needle to collect the eggs from your ovaries. It is typically done under sedation and takes about 20-30 minutes.

Recovery: After the retrieval, you may experience mild discomfort or cramping, but most donors recover quickly and can resume normal activities within a day or two.

Legal and Ethical Considerations

Before becoming an egg donor Toronto, it is crucial to understand the legal and ethical considerations involved. In Canada, egg donation is regulated to ensure the safety and well-being of both donors and recipients. Key points to consider include:

Informed Consent: You must provide informed consent, acknowledging that you understand the risks and benefits of the procedure.

Anonymity and Confidentiality: Many egg donation programs in Toronto offer anonymous donations, meaning your identity will not be disclosed to the recipient, and vice versa. However, some programs may allow for open donations, where the donor and recipient can meet and share information.

Compensation: In Canada, it is illegal to receive payment for egg donation. However, donors can be reimbursed for reasonable expenses incurred during the donation process, such as travel and medical costs.

Potential Risks and Side Effects

While egg donation is generally safe, there are potential risks and side effects to be aware of. These may include:

Ovarian Hyperstimulation Syndrome (OHSS): A condition where the ovaries become swollen and painful due to the hormonal medications. Severe cases are rare but can require medical attention.

Infection or Bleeding: As with any surgical procedure, there is a risk of infection or bleeding during the egg retrieval process.

Emotional Impact: Donating eggs can have emotional implications. It is essential to have a support system and access to counseling if needed.

Conclusion

Becoming an egg donor Toronto is a selfless act that can bring immense joy to families struggling with infertility. By understanding the process, requirements, and potential risks, you can make an informed decision about whether egg donation is right for you. Always consult with medical professionals and consider the emotional and legal aspects before embarking on this life-changing journey.

[industrynewsupdates]

A Deep Dive into the Fusion Biopsy Market: Insights and Analysis

The global fusion biopsy market size is expected to reach USD 1.2 billion by 2030, registering a CAGR of 8.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of prostate cancer, growing demand for targeted biopsy, and the rising utilization rate of multipara metric MRI in prostate cancer care are factors expected to drive the market during the forecast period. Moreover, factors such as rising awareness of the value of routine therapeutic interventions and emerging reimbursement policies are projected to drive demand in the market for fusion biopsy.

The high sensitivity and specificity of targeted fusion biopsy in delineating prostate lesions compared to other traditional technologies such as TRUS biopsy, PSA test, or Digital Rectal Examination is expected to contribute to the market growth. The reliability & reproducibility of the fusion biopsy system in the diagnosis of aggressive tumors is expected to make it a standard tool in prostate biopsy. An increasing number of radiologists gaining expertise in interpreting prostate MRI, coupled with the implementation of standard image grading systems such as PI-RADS and Gleason score, has increased the utilization rate of targeted MR/Ultrasound fusion biopsy systems.

The increasing number of government initiatives in terms of funding research, spreading awareness, and conducting mass screening programs related to prostate cancer are expected to play a crucial in the growth of the market. Some of the growth strategies adopted by market players include partnerships, product launches, participation in trade events and conferences, and acquisitions to drive and sustain growth in this highly competitive space.

Gather more insights about the market drivers, restrains and growth of the Fusion Biopsy Market

Fusion Biopsy Market Report Highlights

• The transrectal segment held the largest market share in 2024, as it is the gold standard and commonly used method of prostate fusion biopsy

• The transperineal segment is expected to grow at the fastest rate during the forecast period owing to the safety, diagnostic efficiency, and ability to access ventral prostate areas

• The hospital segment accounted for the largest revenue share in 2024, owing to factors such as the increasing procurement rate of MR/US targeted fusion biopsy systems in teaching hospitals

• The diagnostics centers segment is expected to expand at a significant rate over the forecast period. Shorter wait times, cost efficiency, and developing reimbursement paradigm are the factors expected to drive the growth of this segment

• North America held the largest market share in 2024 and is anticipated to maintain its dominance over the forecast period

Fusion Biopsy Market Segmentation

Grand View Research has segmented the global fusion biopsy market based on biopsy route, end use, region:

Fusion Biopsy Route Outlook (Revenue, USD Million, 2018 - 2030)

• Transrectal

• Transperineal

Fusion Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostic Centers

• Ambulatory Care Centers

Fusion Biopsy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o Thailand

o South Korea

o Australia

• Latin America

o Brazil

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Fusion Biopsy Market Intelligence Study, published by Grand View Research.

[cnih]

Know More About Ultrasound Program Canada

Are you seeking an Ultrasound Program in Canada? You can count on us. Our campus accommodates 26 dental operatories, materials labs, x-ray labs, technology-enhanced classrooms, a library, personal and change room lockers. We have invested heavily in acquiring the latest ultrasound equipment and imaging technology. We ensure the best services. For more information, you can call us at 613.726.CNIH (2644) or 1.866.726.CNIH (2644).

[goldenmaplephysiotherapy]

From Hockey Injury to Hiking Hero: How Physio Gets You Moving Again

Do you dream of conquering mountain trails but find yourself sidelined by a nagging hockey injury? Don’t let a sports setback keep you from reaching your peak! Here at Physio Maple Ridge, we understand the active spirit that drives Canadians. Our team of experienced physiotherapists in Maple Ridge, BC, is dedicated to getting you back to the activities you love, pain-free.

From Rink to Rehab: Common Hockey Injuries We Treat

Hockey is a fast-paced sport that can put a strain on your body. Here are some common hockey injuries we can help you recover from:

Shoulder strains and rotator cuff injuries

Knee sprains and ACL tears

Groin pulls and tears

Lower back pain

Ankle sprains

Physiotherapy Maple Ridge: Your Path to Recovery

Our personalized physiotherapy treatment plans combine manual therapy techniques, therapeutic exercise programs, and modalities like ultrasound and electrical stimulation to:

Reduce pain and inflammation

Improve range of motion

Strengthen muscles and ligaments

Enhance balance and coordination

Educate you on injury prevention

Beyond the Ice: Physiotherapy for All Your Active Needs

Whether you’re a weekend warrior or a fitness enthusiast, physiotherapy can benefit you. We can help with various conditions, including:

Chronic pain management

Post-surgical rehabilitation

Work-related injuries

Arthritis management

Sports injuries (not just hockey!)

The Golden Connection: Physiotherapy Across Canada

Did you know that Physio Maple Ridge is part of the Golden Maple Physiotherapy network? This network of clinics across Canada shares a commitment to providing exceptional physiotherapy care. So, wherever you are in Canada, you can find a Golden Maple Physiotherapy clinic nearby to help you get back to moving with confidence.

Your Journey to Becoming a Hiking Hero Starts Here

At Physio Maple Ridge, we don’t just treat injuries; we empower you to reach your full potential. We’ll work with you to create a customized treatment plan that gets you back on the ice, hiking trails, or wherever your active lifestyle takes you.

Here’s what makes Physio Maple Ridge different:

Experienced and Certified Physiotherapists with a passion for helping you achieve your goals.

A Commitment to Personalized Care: We take the time to understand your unique needs and develop a treatment plan tailored to you.

State-of-the-Art Facilities: We utilize the latest equipment and techniques to optimize your recovery journey.

Convenient Location: Located in Maple Ridge, BC, making physiotherapy accessible for you.

Part of the Golden Maple Physiotherapy Network: Connected to a national network of clinics providing exceptional care across Canada.

Ready to Take the First Step?

Don’t let pain hold you back from conquering your next adventure. Contact Physio Maple Ridge today for a consultation. Our team will assess your injury, develop a personalized treatment plan, and get you back to moving with confidence.

Together, we’ll turn your hockey injury into a distant memory and help you become the hiking hero you were meant to be!